1. Home
  2. QADR vs WHWK Comparison

QADR vs WHWK Comparison

Compare QADR & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QADR

QDRO Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$9.92

Market Cap

248.0M

Sector

Finance

ML Signal

N/A

Logo Whitehawk Therapeutics Inc.

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$3.71

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QADR
WHWK
Founded
N/A
2007
Country
United States
United States
Employees
N/A
23
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.0M
187.4M
IPO Year
2026
N/A

Fundamental Metrics

Financial Performance
Metric
QADR
WHWK
Price
$9.92
$3.71
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.50
AVG Volume (30 Days)
49.5K
641.0K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.91
$1.57
52 Week High
$10.09
$5.50

Technical Indicators

Market Signals
Indicator
QADR
WHWK
Relative Strength Index (RSI) 48.28 41.30
Support Level $9.91 $3.70
Resistance Level $9.97 $3.79
Average True Range (ATR) 0.01 0.25
MACD -0.00 -0.01
Stochastic Oscillator 12.50 15.79

Price Performance

Historical Comparison
QADR
WHWK

About QADR QDRO Acquisition Corp. Class A Ordinary Shares

QDRO Acquisition Corp is a blank check company.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Share on Social Networks: